In particular, targeting MUC5AC is of clinical relevance, as its overproduction has been implicated in severe muco-obstruction in COPD, whereas a marked suppression or loss of MUC5B secretion may impair host defence. The gene discussed is MUC5B; the disease is chronic obstructive pulmonary disease.